Pierre Gravier
Chief Financial Officer at PTC Therapeutics · 5 reported transactions in 1 company · latest trade Jul 14, 2026
Their trades
Sold | Jul 14, 2026 | Jul 14, 2026 close $78.06 → Oct 30, 2026 close $59.97. S&P 500 +0.5% over the same days. | ||
Sold | Feb 18, 2026 | Feb 18, 2026 close $68.93 → Oct 30, 2026 close $59.97. S&P 500 +10.1% over the same days. | ||
Sold | Jan 6, 2026 | Jan 6, 2026 close $76.70 → Oct 30, 2026 close $59.97. S&P 500 +9.2% over the same days. | ||
Sold | Jul 15, 2025 | Jul 15, 2025 close $47.75 → Oct 30, 2026 close $59.97. S&P 500 +21.5% over the same days. |
SoldPTC Therapeutics
$280.7K
Jul 14, 2026 close $78.06 → Oct 30, 2026 close $59.97. S&P 500 +0.5% over the same days.
SoldPTC Therapeutics
$207.5K
Feb 18, 2026 close $68.93 → Oct 30, 2026 close $59.97. S&P 500 +10.1% over the same days.
SoldPTC Therapeutics
$164.6K
Jan 6, 2026 close $76.70 → Oct 30, 2026 close $59.97. S&P 500 +9.2% over the same days.
SoldPTC Therapeutics
$124.4K
Jul 15, 2025 close $47.75 → Oct 30, 2026 close $59.97. S&P 500 +21.5% over the same days.